Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy

Abstract

Spinal muscular atrophy (SMA) is a motor neuron disease characterized by degeneration of the anterior horn cells of the spinal cord. It is a common fatal autosomal recessive disorder and linkage studies have identified two candidate genes, SMN (ref. 1) and NAIP (ref. 2), both on chromosome 5q13. Although NAIP protein is known to have an anti-apoptotic function3, the function of SMN has been unclear and it shows no significant sequence similarity to any other protein. The SMN gene is deleted or interrupted on both chromosomes in nearly all SMA patients1. Here we show that SMN interacts with Bcl-2, another anti-apoptotic protein4, and that co-expression of SMN with Bcl-2 confers a synergistic preventive effect against Bax-induced or Fas-mediated apoptosis, although SMN itself has only a weak anti-apoptotic activity. SMNY272C, which carries a missense mutation and was found in an SMA patient who exceptionally retained SMN on one allele1, exerts no synergism with Bcl-2. Furthermore, the product of a truncated transcript lacking exon 7, which was derived from an SMN gene carrying an intragenic mutation or from the SMN copy gene c BCD541 (ref. 1) retained in all SMA patients, had no synergistic activity but instead had a dominant-negative effect on full-length SMN. Our results indicate that an absent or decreased anti-apoptotic activity of SMN in concert with Bcl-2 underlies the pathogenesis of SMA.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Co-immunoprecipitation of human Bcl-2 and SMN.
Figure 2: Intracellular localization of SMN protein.
Figure 3: Fluorescence microscope analysis of synergistic prevention of Bax-induced apoptosis by SMN and Bcl-2.
Figure 4: a, Per cent inhibition of Bax-induced apoptosis by hBcl-2, cBcl-2 and SMN.

Similar content being viewed by others

References

  1. Lefebvre, S. et al . Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155–165 (1995).

    Article  CAS  Google Scholar 

  2. Roy, N. et al . The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80, 167–178 (1995).

    Article  CAS  Google Scholar 

  3. Liston, P. et al . Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379, 349–353 (1996).

    Article  ADS  CAS  Google Scholar 

  4. Gajewski, T. F. & Thompson, C. B. Apoptosis meets signal transduction: elimination of a BAD influence. Cell 87, 589–592 (1996).

    Article  CAS  Google Scholar 

  5. Yang, E. et al . Bad, a heterodimeric partner for Bcl-xLand Bcl-2, displaces Bax and promotes cell death. Cell 80, 285–291 (1995).

    Article  CAS  Google Scholar 

  6. Liu, Q. & Dreyfuss, G. Anovel nuclear structure containing the survival of motor neuron proteins. EMBO J. 15, 3555–3565 (1996).

    Article  CAS  Google Scholar 

  7. Krajewski, S. et al . Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53, 4701–4714 (1993).

    CAS  PubMed  Google Scholar 

  8. Akao, Y., Otsuki, Y., Kataoka, S., Itoh, Y. & Tsujimoto, Y. Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes. Cancer Res. 54, 2468–2471 (1994).

    CAS  PubMed  Google Scholar 

  9. Deckwerth, T. L. et al . Bax is required for neuronal death after trophic factor deprivation and during development. Neuron 17, 401–411 (1996).

    Article  CAS  Google Scholar 

  10. Bussaglia, E. et al . Aframeshift deletion in the survival motor neurons gene in Spanish spinal muscular atrophy patients. Nature Genet. 11, 335–337 (1995).

    Article  CAS  Google Scholar 

  11. Gennarelli, M. et al . Survival motor neurons gene transcript analysis in muscles from spinal muscular atrophy patients. Biochem. Biophys. Res. Commun. 213, 342–348 (1995).

    Article  CAS  Google Scholar 

  12. Eguchi, Y., Ewert, D. L. & Tsujimoto, Y. Isolation and characterization of the chicken bcl-2 gene: expression in a variety of tissues including lymphoid and neuronal organs in adult and embryo. Nucleic Acids Res. 20, 4187–4192 (1992).

    Article  CAS  Google Scholar 

  13. Muchmore, S. W. et al . X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381, 335–341 (1996).

    Article  ADS  CAS  Google Scholar 

  14. Chang, B. S., Minn, A. J., Muchmore, S. W., Fesik, S. W. & Thompson, C. B. Identification of a novel regulatory domain in Bcl-xLand Bcl-2. EMBO J. 16, 968–977 (1997).

    Article  CAS  Google Scholar 

  15. Burlet, P. et al . Large scale deletions of the 5q13 region are specific to Werdnig-Hoffmann disease. J. Med. Genet. 33, 281–283 (1996).

    Article  CAS  Google Scholar 

  16. Michaelidis, T. M. et al . Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development. Neuron 17, 75–89 (1996).

    Article  CAS  Google Scholar 

  17. Merry, D. E., Veis, D. J., Hickey, W. F. & Korsmeyer, S. J. Bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 120, 301–311 (1994).

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank J. Miyazaki, A. Shinohara and D. Y. Mason for their kind gifts of pCAGGS-BMG plasmid, pBTM116-RAD51 and anti-hBcl-2 mAb, respectively; T. Hachiya and M. Ikeda for their help in generating antibodies; and M. Hoffman for editorial assistance. This work was supported in part by grants for Scientific Research on Priority Areas and for COE Research from the Ministry of Education, Science, and Culture of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshihide Tsujimoto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iwahashi, H., Eguchi, Y., Yasuhara, N. et al. Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy. Nature 390, 413–417 (1997). https://doi.org/10.1038/37144

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/37144

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing